Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia

被引:56
作者
Muraoka, K
Ishii, E
Tsuji, K
Yamamoto, S
Yamaguchi, H
Hara, T
Koga, H
Nakahata, T
Miyazaki, S
机构
[1] SAGA PREFECTURAL HOSP KOSEIKAN,DIV PAEDIAT,SAGA 840,JAPAN
[2] SAGA MED SCH,DEPT PEDIAT,SAGA,JAPAN
[3] UNIV TOKYO,INST MED SCI,DEPT CLIN ONCOL,TOKYO,JAPAN
关键词
amegakaryocytic thrombocytopenia; thrombopoietin; colony formation; c-mpl mRNA;
D O I
10.1046/j.1365-2141.1997.d01-2028.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congenital amegakaryocytic thrombocytopenia (CAMT) is an uncommon disorder in newborns and infants, characterized by isolated thrombocytopenia and megakaryocytopenia in the first year without physical anomalies. The defect of thrombopoiesis is not well understood. Recently, thrombopoietin (TPO), the ligand for the c-mpl receptor, was cloned. Accumulating evidence from in vitro and in vivo studies indicate that TPO plays a key role in the regulation of megakaryocytopoiesis. In this study we examined the effect of TPO on megakaryocyte colony formation from a patient with CAMT using a plasma-containing methylcellulose clonal culture. The in vitro results demonstrated a defective response to TPO in megakaryocyte colony formation from bone marrow mononuclear cells (MNC) of the patient, although interleukin-3 (IL-3) but not stem cell factor (SCF) induced only a small number of megakaryocyte colonies, These findings indicated that thrombocytopenia in CAMT could not be corrected by administration of TPO in vitro. Additionally, clonal cultures containing SCF, IL-3, IL-6 and erythropoietin showed decreased numbers of erythroid and myelocytic progenitors in the bone marrow of the patient. The serum TPO level measured by enzyme-linked immunosorbent assay was significantly higher than that in healthy controls. By PCR, marrow MNC from healthy children and from a patient with essential thrombocytosis expressed c-mpl mRNA, whereas no c-mpl mRNA was detected in marrow MNC from the patient with CAMT. There was no difference in the CD34 expression and c-kit mRNA between the CAMT patient and healthy children, The results of this study suggest that the pathophysiology in CAMT may be a defective response to TPO in haemopoietic cells through impaired expression of c-mpl mRNA.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 27 条
[1]   Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl [J].
Alexander, WS ;
Roberts, AW ;
Nicola, NA ;
Li, RL ;
Metcalf, D .
BLOOD, 1996, 87 (06) :2162-2170
[2]   MODULATION OF MEGAKARYOCYTOPOIESIS BY THROMBOPOIETIN - THE C-MPL LIGAND [J].
BANU, N ;
WANG, JF ;
DENG, BJ ;
GROOPMAN, JE ;
AVRAHAM, H .
BLOOD, 1995, 86 (04) :1331-1338
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]  
DEBILI N, 1995, BLOOD, V86, P2516
[5]   STIMULATION OF MEGAKARYOCYTOPOIESIS AND THROMBOPOIESIS BY THE C-MPL LIGAND [J].
DESAUVAGE, FJ ;
HASS, PE ;
SPENCER, SD ;
MALLOY, BE ;
GURNEY, AL ;
SPENCER, SA ;
DARBONNE, WC ;
HENZEL, WJ ;
WONG, SC ;
KUANG, WJ ;
OLES, KJ ;
HULTGREN, B ;
SOLBERG, LA ;
GOEDDEL, DV ;
EATON, DL .
NATURE, 1994, 369 (6481) :533-538
[6]   Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin [J].
deSauvage, FJ ;
CarverMoore, K ;
Luoh, SM ;
Ryan, A ;
Dowd, M ;
Eaton, DL ;
Moore, MW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :651-656
[7]  
FREEDMAN MH, 1990, AM J PEDIAT HEMATOL, V12, P225
[8]   HUMAN MEGAKARYOCYTE PRODUCTION - CELL BIOLOGY AND CLINICAL CONSIDERATIONS [J].
GEWIRTZ, AM ;
HOFFMAN, R .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (01) :43-64
[9]  
GUINAN EC, 1993, BLOOD, V81, P1691
[10]   THROMBOCYTOPENIA IN C-MPL-DEFICIENT MICE [J].
GURNEY, AL ;
CARVERMOORE, K ;
DESAUVAGE, FJ ;
MOORE, MW .
SCIENCE, 1994, 265 (5177) :1445-1447